Study Shows Increased Use of Transradial PCI Does Not Significantly Decrease Overall Vascular Access Site Complications
November 25, 2019—In Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2019;22:2247–2256), David Kopin, MD, published a study examining the trends in primary and secondary vascular access sites and vascular access site complications (VASCs) among patients who underwent percutaneous coronary intervention (PCI).
As reported in JACC: Cardiovascular Interventions, there is a concern that the frequency of transradial PCI will cause operators to lose proficiency in femoral access, thus increasing PCI complications. An increase in secondary access during PCI has also been observed.
To evaluate the use of transradial and transfemoral PCI and their associated VASCs, the study queried data from the BMC2 registry, a prospective, longitudinal, multicenter, statewide registry of vascular surgeries and carotid interventions.
The investigators found an increase in transradial PCI from 25.9% in 2013 to 45.2% in 2017; the overall use of secondary vascular access increased from 4.9% to 8.7% with a minimal change in overall VASCs from 1.2% to 1.4%. Secondary access was associated with increased VASCs (odds ratio [OR], 5.82; 95% confidence interval [CI], 5.26–6.43).
Additionally, although patients treated by operators with the highest radial use were more likely to experience femoral VASCs (adjusted OR, 1.51; 95% CI, 1.08–2.13), they were associated with an overall reduction in all VASCs (adjusted OR, 0.62; 95% CI, 0.46–0.83).
The investigators in JACC: Cardiovascular Interventions concluded that despite the increased use of transradial PCI, there has not been a significant VASC decrease—in part due to increased incidence of femoral VASC and increased use of secondary vascular access. To reduce transradial VASCS, further strategies are needed.
advertisement
Featured Video
Valiant Navion™ Thoracic Stent Graft System
Sponsored by Medtronic UC201907188EE
Related Articles
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Top 5 Articles From October 2019
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
With Sirish A. Kishore, MD; and William C. Dillon, MD, FACC
Top 5 from CIToday's Current Issue
Meeting the Challenge…
By Azeem Latib, MD
Massive Thromboembolism, PFO, and Acute Limb Ischemia
By Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD
Radial Access for the Evaluation of Bypass Grafts
By Moderator: Mirvat Alasnag, MD, FACP, FSCAI, FRCP
Panelists: James Nolan, MBChB, FRCP, MD; Sunil Rao, MD; and Binita Shah, MD, MS, FACC, FSCAI
Compensation and Production Trends for Interventionalists
A look at MedAxiom’s annual report reflecting the continued evolution of the field in terms of physician demand and compensation agreements.
